[1] |
ZHOU Q, LI T, WANG K, et al. Current status of xenotransplantation research and the strategies for preventing xenograft rejection[J]. Front Immunol, 2022, 13: 928173. DOI: 10.3389/fimmu.2022.928173.
|
[2] |
徐小松. ABO血型不相容肾移植治疗终末期肾病的关键临床问题探讨[J]. 重庆医学, 2023, 52(18): 2721-2725,2740. DOI: 10.3969/j.issn.1671-8348.2023.18.001.XU XS. The key clinical issues of ABO blood group system incompatible kidney transplantation in the treatment of end stage renal disease[J]. Chongqing Med, 2023, 52(18): 2721-2725,2740. DOI: 10.3969/j.issn.1671-8348.2023.18.001.
|
[3] |
ANAND RP, LAYER JV, HEJA D, et al. Design and testing of a humanized porcine donor for xenotransplantation[J]. Nature, 2023, 622(7982): 393-401. DOI: 10.1038/s41586-023-06594-4.
|
[4] |
MONTGOMERY RA, STERN JM, LONZE BE, et al. Results of two cases of pig-to-human kidney xenotransplantation[J]. N Engl J Med, 2022, 386(20): 1889-1898. DOI: 10.1056/NEJMoa2120238.
|
[5] |
PORRETT PM, ORANDI BJ, KUMAR V, et al. First clinical-grade porcine kidney xenotransplant using a human decedent model[J]. Am J Transplant, 2022, 22(4): 1037-1053. DOI: 10.1111/ajt.16930.
|
[6] |
高菲, 王煜, 杜嘉祥, 等. 遗传修饰猪模型在生物医学及农业领域研究进展及应用[J]. 遗传, 2023, 45(1): 6-28. DOI: 10.16288/j.yczz.22-313.GAO F, WANG Y, DU JX, et al. Advances and applications of genetically modified pig models in biomedical and agricultural field[J]. Hereditas, 2023, 45(1): 6-28. DOI: 10.16288/j.yczz.22-313.
|
[7] |
周小青, 刘玉, 唐成程, 等. 敲除GGTA1同时表达人白细胞抗原G5的基因修饰猪的构建[J]. 生物工程学报, 2022, 38(3): 1096-1111. DOI: 10.13345/j.cjb.210655.ZHOU XQ, LIU Y, TANG CC, et al. Generation of genetically modified pigs devoid of GGTA1 and expressing the human leukocyte antigen-G5[J]. Chin J Biotechnol, 2022, 38(3): 1096-1111. DOI: 10.13345/j.cjb.210655.
|
[8] |
TECTOR AJ, MOSSER M, TECTOR M, et al. The possible role of anti-Neu5Gc as an obstacle in xenotransplantation[J]. Front Immunol, 2020, 11: 622. DOI: 10.3389/fimmu.2020.00622.
|
[9] |
COOPER DKC, HARA H, IWASE H, et al. Justification of specific genetic modifications in pigs for clinical organ xenotransplantation[J]. Xenotransplantation, 2019, 26(4): e12516. DOI: 10.1111/xen.12516.
|
[10] |
NAGANO F, MIZUNO T, MIZUMOTO S, et al. Chondroitin sulfate protects vascular endothelial cells from toxicities of extracellular histones[J]. Eur J Pharmacol, 2018, 826: 48-55. DOI: 10.1016/j.ejphar.2018.02.043.
|
[11] |
ZHANG G, HARA H, YAMAMOTO T, et al. Serum amyloid a as an indicator of impending xenograft failure: experimental studies[J]. Int J Surg, 2018, 60: 283-290. DOI: 10.1016/j.ijsu.2018.11.027.
|
[12] |
WATANABE H, ARIYOSHI Y, POMPOSELLI T, et al. Intra-bone bone marrow transplantation from hCD47 transgenic pigs to baboons prolongs chimerism to >60 days and promotes increased porcine lung transplant survival[J]. Xenotransplantation, 2020, 27(1): e12552. DOI: 10.1111/xen.12552.
|
[13] |
CIMENO A, KURAVI K, SORRELLS L, et al. hEPCR. hTBM. hCD47. hHO-1 with donor clodronate and DDAVP treatment improves perfusion and function of GalTKO. hCD46 porcine livers perfused with human blood[J]. Xenotransplantation, 2022, 29(2): e12731. DOI: 10.1111/xen.12731.
|
[14] |
HINRICHS A, RIEDEL EO, KLYMIUK N, et al. Growth hormone receptor knockout to reduce the size of donor pigs for preclinical xenotransplantation studies[J]. Xenotransplantation, 2021, 28(2): e12664. DOI: 10.1111/xen.12664.
|
[15] |
MOHIUDDIN MM. Pig-to-primate organ transplants require genetic modifications of donor[J]. Nature, 2023, 622(7982): 244-245. DOI: 10.1038/d41586-023-02817-w.
|
[16] |
KOZLOV M. Monkey survives for two years after gene-edited pig-kidney transplant[J]. Nature, 2023, 622(7983): 437-438. DOI: 10.1038/d41586-023-03176-2.
|
[17] |
SIEMS C, HUDDLESTON S, JOHN R. A brief history of xenotransplantation[J]. Ann Thorac Surg, 2022, 113(3): 706-710. DOI: 10.1016/j.athoracsur.2022.01.005.
|
[18] |
GANCHIKU Y, RIELLA LV. Pig-to-human kidney transplantation using brain-dead donors as recipients: one giant leap, or only one small step for transplantkind?[J]. Xenotransplantation, 2022, 29(3): e12748. DOI: 10.1111/xen.12748.
|
[19] |
中华医学会器官移植学分会异种移植学组. 异种移植临床研究指导意见(2018建议版)[J]. 器官移植, 2018, 9(6): 405-408. DOI: 10.3969/j.issn.1674-7445.2018.06.001.Xenotransplantation Group of Organ Transplantation Credit Association of Chinese Medical Association. Guidelines for clinical research of xenotransplantation (2018 recommended version) [J]. Organ Transplant, 2018, 9(6): 405408. DOI: 10.3969/j.issn.1674-7445.2018.06.001.
|
[20] |
YU XH, DENG WY, JIANG HT, et al. Kidney xenotransplantation: recent progress in preclinical research[J]. Clin Chim Acta, 2021, 514: 15-23. DOI: 10.1016/j.cca.2020.11.028.
|
[21] |
LADOWSKI JM, HARA H, COOPER DKC. The role of SLAs in xenotransplantation[J]. Transplantation, 2021, 105(2): 300-307. DOI: 10.1097/TP.0000000000003303.
|
[22] |
HARA H, NGUYEN H, WANG ZY, et al. Evidence that sensitization to triple-knockout pig cells will not be detrimental to subsequent allotransplantation[J]. Xenotransplantation, 2021, 28(4): e12701. DOI: 10.1111/xen.12701.
|
[23] |
MOHIUDDIN MM, SINGH AK, CORCORAN PC, et al. Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO. hCD46. hTBM pig-to-primate cardiac xenograft[J]. Nat Commun, 2016, 7: 11138. DOI: 10.1038/ncomms11138.
|
[24] |
ADAMS AB, KIM SC, MARTENS GR, et al. Xenoantigen deletion and chemical immunosuppression can prolong renal xenograft survival[J]. Ann Surg, 2018, 268(4): 564-573. DOI: 10.1097/SLA.000000000000 2977.
|
[25] |
ANWAR IJ, DELAURA I, LADOWSKI J, et al. Complement-targeted therapies in kidney transplantation-insights from preclinical studies[J]. Front Immunol, 2022, 13: 984090. DOI: 10.3389/fimmu.2022.984090.
|
[26] |
VIGLIETTI D, GOSSET C, LOUPY A, et al. C1 inhibitor in acute antibody-mediated rejection nonresponsive to conventional therapy in kidney transplant recipients: a pilot study[J]. Am J Transplant, 2016, 16(5): 1596-1603. DOI: 10.1111/ajt.13663.
|
[27] |
RÖTH A, BARCELLINI W, D'SA S, et al. Sutimlimab in cold agglutinin disease[J]. N Engl J Med, 2021, 384(14): 1323-1334. DOI: 10.1056/NEJMoa2027760.
|
[28] |
ESKANDARY F, JILMA B, MÜHLBACHER J, et al. Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejection-results from a first-in-patient phase 1 trial[J]. Am J Transplant, 2018, 18(4): 916-926. DOI: 10.1111/ajt.14528.
|
[29] |
ADAMS AB, LOVASIK BP, FABER DA, et al. Anti-C5 antibody tesidolumab reduces early antibody-mediated rejection and prolongs survival in renal xenotransplantation[J]. Ann Surg, 2021, 274(3): 473-480. DOI: 10.1097/SLA.0000000000004996.
|
[30] |
GAO Y, SHAN W, GU T, et al. Daratumumab prevents experimental xenogeneic graft-versus-host disease by skewing proportions of T cell functional subsets and inhibiting T cell activation and migration[J]. Front Immunol, 2021, 12: 785774. DOI: 10.3389/fimmu.2021.785774.
|
[31] |
BOCKERMANN R, JÄRNUM S, RUNSTRÖM A, et al. Imlifidase-generated single-cleaved IgG: implications for transplantation[J]. Transplantation, 2022, 106(7): 1485-1496. DOI: 10.1097/TP.0000000000004031.
|
[32] |
DELAURA I, ZIKOS J, ANWAR IJ, et al. The impact of IdeS (imlifidase) on allo-specific, xeno-reactive, and protective antibodies in a sensitized rhesus macaque model[J]. Xenotransplantation, 2023, DOI: 10.1111/xen.12833[Epub ahead of print
|
[33] |
HANSEN-ESTRUCH C, COOPER DKC, JUDD E. Physiological aspects of pig kidney xenotransplantation and implications for management following transplant[J]. Xenotransplantation, 2022, 29(3): e12743. DOI: 10.1111/xen.12743.
|
[34] |
HANSEN-ESTRUCH C, BIKHET MH, JAVED M, et al. Renin-angiotensin-aldosterone system function in the pig-to-baboon kidney xenotransplantation model[J]. Am J Transplant, 2023, 23(3): 353-365. DOI: 10.1016/j.ajt.2022.11.022.
|
[35] |
FIRL DJ, MARKMANN JF. Measuring success in pig to non-human-primate renal xenotransplantation: systematic review and comparative outcomes analysis of 1051 life-sustaining NHP renal allo- and xeno-transplants[J]. Am J Transplant, 2022, 22(6): 1527-1536. DOI: 10.1111/ajt.16994.
|
[36] |
KIM SC, MATHEWS DV, BREEDEN CP, et al. Long-term survival of pig-to-rhesus macaque renal xenografts is dependent on CD4 T cell depletion[J]. Am J Transplant, 2019, 19(8): 2174-2185. DOI: 10.1111/ajt.15329.
|
[37] |
IWASE H, HARA H, EZZELARAB M, et al. Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts[J]. Xenotransplantation, 2017, 24(2):e12293. DOI: 10.1111/xen.12293.
|
[38] |
LI T, JIANG H, LIU H, et al. Extracellular histones and xenotransplantation[J]. Xenotransplantation, 2020, 27(5): e12618. DOI: 10.1111/xen.12618.
|
[39] |
LU T, YANG B, WANG R, et al. Xenotransplantation: current status in preclinical research[J]. Front Immunol, 2020, 10: 3060. DOI: 10.3389/fimmu.2019.03060.
|
[40] |
宋佳华, 余一凡, 邓文艺, 等. 异种肾移植: 生理学研究的现状及发展趋势[J]. 器官移植, 2023, 14(6): 898-904. DOI: 10.3969/j.issn.1674-7445.2023148.SONG JH, YU YF, DENG WY, et al. Kidney xenotransplantation: the present situation and development trend of physiological research[J]. Organ Transplant, 2023, 14(6): 898-904. DOI: 10.3969/j.issn.1674-7445.2023148.
|
[41] |
BOSE S, VOLPATTI LR, THIONO D, et al. A retrievable implant for the long-term encapsulation and survival of therapeutic xenogeneic cells[J]. Nat Biomed Eng, 2020, 4(8): 814-826. DOI: 10.1038/s41551-020-0538-5.
|
[42] |
蒋鸿涛, 李涛, 何松哲, 等. 基因修饰猪-非人灵长类动物异种肾移植面临的问题及挑战[J]. 器官移植, 2022, 13(6): 810-817. DOI: 10.3969/j.issn.1674-7445.2022.06.018.JIANG HT, LI T, HE SZ, et al. Problems and challenges of genetically modified pig-non-human primate xenotransplantation[J]. Organ Transplant, 2022, 13(6): 810-817. DOI: 10.3969/j.issn.1674-7445.2022.06.018.
|
[43] |
DENNER J. Porcine endogenous retroviruses and xenotransplantation, 2021[J]. Viruses, 2021, 13(11): 2156. DOI: 10.3390/v13112156.
|
[44] |
曾嘉庆, 高岩, 仇相书, 等. 猪逆转录病毒SYBR Green Ⅰ荧光定量PCR检测方法的建立及应用[J]. 中国病原生物学杂志, 2022, 17(1): 26-30. DOI: 10.13350/j.cjpb.220107.ZENG JQ, GAO Y, QIU XS, et al. Establishment and application of fluorescence quantitative PCR for detection of porcine retrovirus SYBR Green Ⅰ[J]. Chin J Pathog Biolo, 2022, 17(1): 26-30. DOI: 10.13350/j.cjpb.220107.
|
[45] |
PISANO MP, GRANDI N, TRAMONTANO E. High-throughput sequencing is a crucial tool to investigate the contribution of human endogenous retroviruses (HERVs) to human biology and development[J]. Viruses, 2020, 12(6): 633. DOI: 10.3390/v12060633.
|
[46] |
GU W, ZENG N, ZHOU L, et al. Genomic organization and molecular characterization of porcine cytomegalovirus[J]. Virology, 2014, 460/461: 165-172. DOI: 10.1016/j.virol.2014.05.014.
|
[47] |
GRIFFITH BP, GOERLICH CE, SINGH AK, et al. Genetically modified porcine-to-human cardiac xenotransplantation[J]. N Engl J Med, 2022, 387(1): 35-44. DOI: 10.1056/NEJMoa2201422.
|
[48] |
DENNER J, LÄNGIN M, REICHART B, et al. Impact of porcine cytomegalovirus on long-term orthotopic cardiac xenotransplant survival[J]. Sci Rep, 2020, 10(1): 17531. DOI: 10.1038/s41598-020-73150-9.
|
[49] |
HALECKER S, HANSEN S, KRABBEN L, et al. How, where and when to screen for porcine cytomegalovirus (PCMV) in donor pigs for xenotransplantation[J]. Sci Rep, 2022, 12(1): 21545. DOI: 10.1038/s41598-022-25624-1.
|
[50] |
SINGH AK, GRIFFITH BP, GOERLICH CE, et al. The road to the first FDA-approved genetically engineered pig heart transplantation into human[J]. Xenotransplantation, 2022, 29(5): e12776. DOI: 10.1111/xen.12776.
|
[51] |
GARDINER D, MCGEE A, SIMPSON C, et al. Baseline ethical principles and a framework for evaluation of policies: recommendations from an international consensus forum[J]. Transplant Direct, 2023, 9(5): e1471. DOI: 10.1097/TXD.0000000000001471.
|
[52] |
徐莹, 陈佳弘, 何松哲, 等. 移植相关人群对异种肾移植的态度及影响因素[J]. 器官移植, 2023, 14(5): 683-690. DOI: 10.3969/j.issn.1674-7445.2023118.XU Y, CHEN JH, HE SZ, et al. Attitude and influencing factors of transplant-related population towards kidney xenotransplantation[J]. Organ Transplant, 2023, 14(5): 683-690. DOI: 10.3969/j.issn.1674-7445.2023118.
|